Picks of the quarter Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Picks of the quarter

ATHR 5.890

+1.6%

3:30 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Elroy who wrote (18465)	12/18/2015 12:42:58 PM
From: Bonefish	of 20435

Fat chance of it opening now. The Lawyers have moved in. KaloBios Pharmaceuticals, Inc. - Information Request FormLevi & Korsinsky, LLP announces that it has commenced an investigation of KaloBios Pharmaceuticals, Inc. ("KaloBios" or the "Company") (NASDAQGM: KBIO) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On December 17, 2015, news outlets reported that Martin Shkreli, the CEO of KaloBios, was arrested on securities fraud charges relating to his illegal use of stock from Retrophin Inc. to pay off debts associated with other unrelated business ventures. On this news, KaloBios shares plummeted pre-market, and trading has since been halted. To receive more information regarding the investigation of KaloBios please fill out the form below. zlkdocs.com marketwatch.com My best guess is it's worth closer to ZERO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next